I. Sección vigilancia farmacológica: B: farmacovigilancia: COX-2: el 28 de febrero de 2005, la OMS comunica las medidas adoptadas por diversas agencias reguladoras por los severos efectos cardiotoxicos del grupo (Australia, EMEA, NZ, FDA) / I. Pharmacological monitoring section: B: pharmacovigilance: COX-2: 28th of February to 2005, WHO communicates the measures adopted by diverse regulating agencies by the severe cardiotoxic effects the group (Australia, EMEA, NZ, FDA)
Bol. inf. medicam. (Santiago de Chile)
;
22(1/2): 26-27, sept. 2005.
Article
in Spanish
| LILACS
| ID: lil-439449
Search on Google
Index:
LILACS (Americas)
Main subject:
Cyclooxygenase Inhibitors
Type of study:
Screening study
Language:
Spanish
Journal:
Bol. inf. medicam. (Santiago de Chile)
Journal subject:
Pharmacology
Year:
2005
Type:
Article
Similar
MEDLINE
...
LILACS
LIS